Persistent Depressive Disorder
15
4
5
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 15 trials
100.0%
+13.5% vs benchmark
7%
1 trials in Phase 3/4
29%
2 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (15)
Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings
Individualized (fMRI-guided) TMS Treatment for Depression
Personalized Indications for CBT and Antidepressants in Treating Depression
Effectiveness of an Ecological Momentary Emotion Regulation Intervention
Imagery Rescripting as Treatment for Depression
Effects of Mindfulness on Brain Functioning in Depressed Patients
Blended Mindfulness-Based Intervention for Persistent Depression
A Comparison of Two Psychotherapy Programs in Persistently Depressed Treatment-Resistant Inpatients
Transdiagnostic Internet-delivered REBT Intervention for Adolescents' Internalizing Problems
Personalized, Predictive, Precise & Preventive Medicine for Major Depression
Using Sleep Wearables to Adapt Cognitive-behavioral Therapy for Insomnia in the Context of Depression (CBTiA)
Intensive Psychotherapy for Chronic Depression
Feasibility and Effectiveness of a Personalized Inpatient Program for Persistent Depressive Disorder
Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders
Behavioral Activation (BA) for Medication-responsive Chronically Depressed Patients With Impaired Social Functioning